Citation

BibTex format

@article{Perren:2011:10.1056/NEJMoa1103799,
author = {Perren, TJ and Swart, AM and Pfisterer, J and Ledermann, JA and Pujade-Lauraine, E and Kristensen, G and Carey, MS and Beale, P and Cervantes, A and Kurzeder, C and du, Bois A and Sehouli, J and Kimmig, R and Staehle, A and Collinson, F and Essapen, S and Gourley, C and Lortholary, A and Selle, F and Mirza, MR and Leminen, A and Plante, M and Stark, D and Qian, W and Parmar, MKB and Oza, AM},
doi = {10.1056/NEJMoa1103799},
journal = {NEW ENGLAND JOURNAL OF MEDICINE},
pages = {2484--2496},
title = {A Phase 3 Trial of Bevacizumab in Ovarian Cancer},
url = {http://dx.doi.org/10.1056/NEJMoa1103799},
volume = {365},
year = {2011}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Perren,TJ
AU  - Swart,AM
AU  - Pfisterer,J
AU  - Ledermann,JA
AU  - Pujade-Lauraine,E
AU  - Kristensen,G
AU  - Carey,MS
AU  - Beale,P
AU  - Cervantes,A
AU  - Kurzeder,C
AU  - du,Bois A
AU  - Sehouli,J
AU  - Kimmig,R
AU  - Staehle,A
AU  - Collinson,F
AU  - Essapen,S
AU  - Gourley,C
AU  - Lortholary,A
AU  - Selle,F
AU  - Mirza,MR
AU  - Leminen,A
AU  - Plante,M
AU  - Stark,D
AU  - Qian,W
AU  - Parmar,MKB
AU  - Oza,AM
DO  - 10.1056/NEJMoa1103799
EP  - 2496
PY  - 2011///
SN  - 0028-4793
SP  - 2484
TI  - A Phase 3 Trial of Bevacizumab in Ovarian Cancer
T2  - NEW ENGLAND JOURNAL OF MEDICINE
UR  - http://dx.doi.org/10.1056/NEJMoa1103799
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000298544600009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 365
ER  -
Download